AI assistant
GILEAD SCIENCES, INC. — Director's Dealing 2019
May 10, 2019
29828_dirs_2019-05-10_274d5a88-b2de-4b06-b25f-4261cdd263fe.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2019-05-08
Reporting Person: Whitley Richard James (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-05-08 | Restricted Stock Unit | $ | A | 2270 | Acquired | Common Stock (2270) | Direct | |
| 2019-05-08 | Non-qualified Stock Option (Right to Buy) | $66.07 | A | 11848 | Acquired | 2029-05-08 | Common Stock (11848) | Direct |
Footnotes
F1: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2: 100% of the restricted stock units will vest upon the earlier of May 8, 2020, or the day immediately preceding the next regular annual stockholders meeting.
F3: 25% of the shares subject to the option vest on each three-month anniversary from May 8, 2019 such that 100% of the shares subject to the option will be fully vested and exercisable upon the earlier of May 8, 2020 or the day immediately preceding the next regular annual stockholders meeting.